Zaven Kaprielian

DDF Discovery

Zaven brings over 25 years of Neuroscience research to the Dementia Discovery Fund U.S. Discovery team

In June 2018, Zaven joined the Dementia Discovery Fund U.S. Discovery (“DUS”) team as lead of the Daionus project, which aims to develop effective treatments for Alzheimer’s disease and other dementias by rescuing disease-associated endo-lysosomal trafficking defects.

Prior experience
From June 2013 to June 2018, Zaven was a Director of Neuroscience Research at Amgen in Cambridge, MA.  In this role, he managed several teams and programs tasked with identifying novel therapeutics for neuropathic pain and neurodegenerative disorders, with a focus on ALS and Parkinson’s Disease.  Zaven also chaired the Amgen Massachusetts External Outreach committee, which was charged with increasing the visibility of Amgen, and leveraging the local health sciences ecosystem to enhance innovation.  Prior to working in industry, Zaven was a faculty member at the Albert Einstein College of Medicine, where he directed a basic science research group focused on the molecular mechanisms that control axon guidance and dendrite branching in the developing central nervous system.

Academic credentials
B.S. in Aerospace Engineering
M.A. in Physics from Boston University
Ph.D. in Biophysics from The Johns Hopkins University
Postdoctoral Research at the California Institute of Technology (Caltech)

Outside of SV
Zaven enjoys fishing, gardening and amateur meteorology

Dementia Discovery Fund